Table 3 Overall and Progression free survival in Patients receiving only PD-1 therapy
Cohort A (No Metformin) | Cohort B (Metformin) |
|---|---|
Overall Survival | |
 • 64.6% patients alive at 1 year | • 100% patients alive at 1 year |
 • 55.4% patients alive at 2 years | • 72.9% patients alive at 2 years |
Progression Free Survival | |
 • 36.3% patients free from progression at 1 year | • 59.6% patients free from progression at 1 year |
 • 27.2% patients free from progression at 2 years | • 47.6% patients free from progression at 2 years |